Predictors of Readmission in Patients Undergoing PNL

Sponsor
Assiut University (Other)
Overall Status
Completed
CT.gov ID
NCT05852483
Collaborator
(none)
161
1
8
20.1

Study Details

Study Description

Brief Summary

To identify predictors of patients postoperative readmission after PNL

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Percutaneous nephrolithotomy (PCNL) is a minimally-invasive procedure to remove stones from the kidney by a small puncture wound (up to about 1 cm) through the skin. It is usually done under general anesthesia or spinal anesthesia. Despite the advancements in endoscopic technologies technique and training, the procedure is still associated with complications, which can occur during the intervention or in the early or late postoperative period. Known complications to PCNL are fever (2.8-32.1%), bleeding requiring transfusion (0- 45%), organ injury (0-1.7%) and sepsis (0.3-1.5%) these complications consider life threatening and increase risk of patient readmission Readmission is defined as a state when the patient is admitted to the same or a different hospital after being discharged from the applicable hospital to a non-acute setting, such as his home within a specified time period . Hospital readmissions are frequent and costly, and are estimated to cost the US health care system > $12-17 billion annually . Readmissions occurring within the first week after discharge are often related to the stress of acute illness as well as heightened self-care needs, new medications, and impaired function while those occurring later reflect chronic illness Nurses could play a pivotal role in preventing readmissions through appropriate discharge teaching and following up with the patients after discharge through telephone conversations. Early identification of patients' problems and taking appropriate measures to handle these problems at an early stage helps to prevent further post-discharge complications and improves patient outcomes.

    Nurse should emphasize to the patient the importance of reporting symptoms to physician immediately. Postoperative care should include: close monitoring of vital signs, close observation of urine output and color changes, wound care and careful observation for dressing and tube drainage.

    Many studies have been found in the literature on readmissions after urological surgeries and their causes in recent years . These studies include general urological surgical procedures, and there are limited studies examining potential predictive factors for endourology and stone surgery

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    161 participants
    Observational Model:
    Cohort
    Time Perspective:
    Retrospective
    Official Title:
    Perioperative Predictors of Postoperative Readmission Among Patients Undergoing Percutaneous Nephrolithotomy
    Actual Study Start Date :
    Apr 1, 2022
    Actual Primary Completion Date :
    Oct 1, 2022
    Actual Study Completion Date :
    Dec 1, 2022

    Outcome Measures

    Primary Outcome Measures

    1. comparison between readmitted and non readmitted regarding readmission risk factors [baseline]

      analysis preioperative factors that lead to readmission after PNL

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 65 Years
    Sexes Eligible for Study:
    All
    Inclusion Criteria:
    • Adult male and female patients

    • patients shechedled for PNL

    • age range from)18-65(years

    Exclusion Criteria:
    • Failed PNL

    • psychiatric patients

    • coagulopathy

    • patients refused to participate in the study

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 faculty of nursing, Assiut University, Egypt Assiut Egypt

    Sponsors and Collaborators

    • Assiut University

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    Responsible Party:
    Hazem Tarraf Abo Dief, principal investigator, Assiut University
    ClinicalTrials.gov Identifier:
    NCT05852483
    Other Study ID Numbers:
    • Post PNL readmission
    First Posted:
    May 10, 2023
    Last Update Posted:
    May 17, 2023
    Last Verified:
    May 1, 2023
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Hazem Tarraf Abo Dief, principal investigator, Assiut University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of May 17, 2023